BiancaMed raises €6M in second round

Funding

BiancaMed has raised €6 million in a second round funding led by Seventure Partners, of France, with three of BiancaMed’s existing investors, ePlanet Ventures, Enterprise Ireland and ResMed following on.

The money will finance the further development and commercialisation of SleepMinder, an accurate, contactless and convenient device for monitoring of sleep and breathing in the home. This new capital will allow BiancaMed to expand its core team and accelerate the launch of several consumer products with existing partners targeting the wellness space. It will also enable the company to continue the development of clinical products targeting unmet needs in areas such as sleep apnoea screening and disease management.

BiancaMed co-founder and CEO Conor Hanley said, “With this new financing we will be able to accelerate the commercial development of our proprietary non-contact, sleep monitoring technology. It is a strong validation of our firm’s technology and strategy that we have secured investment from a new, value-add investor such as Seventure, and the continued support of our existing investors.

BiancaMed is headquartered in NovaUCD, the Innovation and Technology Transfer Centre at University College Dublin. The technology at the core of BiancaMed’s SleepMinder was initially developed at UCD’s School of Electrical, Electronic and Mechanical Engineering by Conor Heneghan, Chief Scientific Officer, and Philip de Chazal, Chief Technology Officer.